权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

EUthyroid2 - The next step towards the elimination of iodine deficiency and preventable iodine-related disorders in Europe

EU甲状腺2 - 欧洲消除碘缺乏症和可预防的碘相关疾病的下一步

基本信息

批准号：
10062205
负责人：
金额：
$ 31.94万
依托单位：
UNIVERSITY OF SURREY
依托单位国家：
英国
项目类别：
EU-Funded
财政年份：
2023
资助国家：
英国
起止时间：
2023 至无数据
项目状态：
未结题

来源：
https://gtr.ukri.org/projects?ref=10062205
关键词：
EUthyroid2 next step towards elimination

项目摘要

The iodine status is a primary determinant of thyroid disorders, which are a major cause of morbidity, particularly in women. In addition, even mild-to-moderate iodine deficiency during pregnancy is related to neurocognitive impairment in the offspring. Iodine deficiency imposes tremendous costs on the health-care systems of affected regions, but can easily be prevented by iodine fortification programmes. In many countries, iodine deficiency receives surprisingly little publicity. The initial EUthyroid consortium evaluated European prevention programmes against iodine deficiency and uncovered major limitations including the low awareness on the importance of iodine for healthy living. EUthyroid2 will now fill important gaps in the prevention of iodine deficiency in Europe and beyond. The main objective of EUthyroid2 is to improve the low awareness with respect to iodine deficiency-related risks in adolescents and young women. The major aim is to find best practice models for accessing and informing them to increase their awareness and to improve their iodine status in order to lay the foundation for their own thyroid and general health and that of their offspring. Implementation studies and community-based randomised-controlled trials will be conducted with the objective of increasing iodinerelated awareness in adolescents and young women up to age of 24 before pregnancy. The interventions are multimodal and performed in the two settings educational system and ambulatory care in eight study regions. As public health project EUthyroid2 is not only science, but will also serve our societies. Therefore, dissemination of findings to various sectors of our countries and the EU will be of utmost importance. By finding best practice models to raise the awareness on the importance of iodine for a healthy life of their own and their offspring in young people, EUthyroid2 will lay the foundation for a cost-effective way to eradicate iodine deficiency-related disorders.

碘营养状况是甲状腺疾病的主要决定因素，而甲状腺疾病是发病的主要原因，特别是在妇女中。此外，即使是妊娠期轻度至中度碘缺乏也与后代的神经认知障碍有关。碘缺乏症给受影响地区的保健系统造成巨大的费用，但通过碘强化方案可以很容易地预防。令人惊讶的是，在许多国家，碘缺乏症很少得到宣传。最初的正常甲状腺联盟评估了欧洲预防碘缺乏病的计划，发现了主要的局限性，包括对碘对健康生活的重要性认识不足。EUthyroid2现在将填补欧洲及其他地区预防碘缺乏症的重要空白。EUthyroid 2的主要目标是改善青少年和年轻女性对碘缺乏相关风险的低认识。其主要目的是寻找最佳做法模式，以便向他们提供信息，提高他们的认识，改善他们的碘营养状况，为他们自己及其后代的甲状腺和一般健康奠定基础。将开展实施研究和社区随机对照试验，目的是提高青少年和24岁以下年轻妇女在怀孕前对碘的认识。这些干预措施是多模式的，在八个研究地区的两个环境、教育系统和门诊护理中进行。作为公共卫生项目，EUthyroid 2不仅是科学，而且还将服务于我们的社会。因此，向我们各国和欧盟各部门传播调查结果至关重要。通过寻找最佳实践模式，提高年轻人对碘对自己和后代健康生活重要性的认识，EUthyroid2将为消除碘缺乏相关疾病的成本效益方式奠定基础。